Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,72082.1%29,79986.3% +7.5%
Vaccines3,97411.8%4,74313.7% +19.35%
Animal Health2,0766.1%---
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
United States11,33933.6%12,24635.5% +8%
Western Europe5,39116%5,24815.2% -2.65%
Latin America3,36310%3,0478.8% -9.4%
Asia3,2059.5%3,53610.2% +10.33%
Eastern Europe and Turkey2,5417.5%2,3666.8% -6.89%
France2,4747.3%2,2486.5% -9.14%
Japan2,1196.3%2,0345.9% -4.01%
Other1,1753.5%229.000.7% -80.51%
Rest of the World1,1003.3%1,3664% +24.18%
Middle East1,0633.1%---
Africa and Middle-East--2,2226.4%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,287,105,713 1,154,406,514 89.7% 100,000 0.0% 89.7%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.17%
Dodge & Cox 27,082,752 2.10%
Norges Bank Investment Management 26,541,076 2.06%
The Vanguard Group, Inc. 23,391,799 1.81%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.72%
Amundi Asset Management SA (Investment Management) 18,630,683 1.45%
Plan d'Epargne Entreprise Sanofi Synthelabo 16,697,049 1.30%
THEAM SAS 14,301,165 1.11%
Lyxor International Asset Management SAS 13,048,470 1.01%
Natixis Asset Management SA 12,823,973 0.99%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%8,079,814,988 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%907,679,975 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%365,136,135 USD
Sanofi (SAN) 3,956,7080.31%307,777,873 USD
Zentiva SA (ROSCD) 312,341,64974.9%151,938,595 USD
Myokardia Inc (MYOK) 3,668,89911.9%49,346,692 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%29,735,292 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.57%13,897,892 USD
Proteome Sciences plc (PRM) 38,0000.017%2,538 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI-4.45%102 757
JOHNSON & JOHNSON8.05%301 952
ROCHE HOLDING LTD.-19.97%189 184
PFIZER INC.-3.38%187 755
NOVARTIS AG-20.79%178 671
MERCK & CO., INC.13.82%165 759
BRISTOL-MYERS SQUIBB C..-19.71%92 302
GLAXOSMITHKLINE PLC6.52%89 608
BAYER AG-24.74%81 779
ELI LILLY AND CO-20.26%74 174
ALLERGAN PLC-39.69%70 691
NOVO NORDISK A/S-39.23%70 014
ASTRAZENECA PLC-12.54%65 712
ABBOTT LABORATORIES-13.87%56 949
SHIRE PLC-7.82%49 405
TAKEDA PHARMACEUTICAL ..-21.73%31 583
ASTELLAS PHARMA INC-10.77%28 716
MYLAN NV-36.19%19 296
EISAI CO., LTD-13.04%16 254
JIANGSU HENGRUI MEDICI..-80.53%16 083
SHIONOGI & CO LTD-9.42%15 067
Sector Pharmaceuticals - NEC
Sanofi : Connections
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem